Aaron Results Through Perseverance

GRAPHIC:
[10-SECOND COUNTDOWN BEGINS]

On-screen Text:
Skyrizi®
risankizumab-rzaa

SKYRIZI is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy).

SAFETY CONSIDERATIONS

SKYRIZI may cause serious side effects, including:

  • Serious allergic reactions: Stop using SKYRIZI and get emergency medical help right away if you get any symptoms of a serious allergic reaction.

  • Infections: SKYRIZI may increase your risk of infections. Before starting treatment, your doctor should check you for infections and tuberculosis. Tell your doctor right away if you have an infection or symptoms of one. 
Do not use SKYRIZI if you are allergic to risankizumab-rzaa or any of the ingredients in SKYRIZI.  
 
Also, tell your doctor if you plan to or recently received a vaccine.
 
Please see additional Important Safety Information near the end of this video. Please see link for the Full Prescribing Information, including the Medication Guide, for SKYRIZI.

GRAPHIC:
[10-SECOND COUNTDOWN BEGINS]
Skyrizi® risankizumab-rzaa

Aaron (V.O.):
My name is Aaron and I have moderate to severe plaque psoriasis.

On-screen Text:
AARON, A SKYRIZI PATIENT

Aaron: ...
Life with clear skin has been awesome.

Aaron:
After 20 years of treatments for my psoriasis, I’ve learned that you cannot give up…

Aaron:
…that I was going to keep fighting until I found something that worked for me.

On-screen Text:
That I was gonna keep fighting until I found something that worked for me.

Aaron (V.O.):
I was just very candid and open with my physician about my desire to try new medications and…

Aaron:
…I just kept working and kept exploring those options and you know that path led me to try SKYRIZI.

Aaron:
It only took a matter of weeks for me to start seeing a big difference.

On-screen Text:
In clinical trials, 3 out of 4 people achieved 90% clearer skin at 4 months, after just two doses.

Aaron:
I could tell the inflammation was dying down...

On-screen Text:
At 4 months, on average, people reported a significant improvement in the pain, itching, burning, and redness of psoriasis, and some even said they had no symptoms.

Aaron:
…I could tell that the itch was reducing…

On-screen Text:
The itch was reducing

Aaron:
…And then, I could start seeing the actual raised areas reducing.

Aaron:
So, I was always a little more excited with each passing day

On-screen Text:
Nearly 6 out of 10 ACHIEVED 100% CLEAR SKIN at 1 year
Nearly 4 out of 10 achieved it at 4 months

Aaron:
…just to see, you know, how exactly clear I could possibly get, which I'm happy to say is 100%.

Aaron:
There was a time when I never thought I would get 100% clearance on my skin, because I felt like I had a case that was severe enough to discourage me.

On-screen Text:
Most who achieved clear skin at 4 months kept it through 1 year.

Aaron:
To know that I’ve been able to achieve that for extended periods of time is just a thrill to me.

Aaron:
Without plaques on my skin, I feel amazing.

On-screen Text:
I feel amazing!

Aaron:
I can go out and think about other stuff that you should be concerned with rather than your skin.

GRAPHIC:
Skyrizi® risankizumab-rzaa

[SCROLLS ON SCREEN]

V.O./On-Screen Text:

USE AND IMPORTANT SAFETY INFORMATION

SKYRIZI® (risankizumab-rzaa) USE

SKYRIZI is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy).

Important Safety Information

What is the most important information I should know about SKYRIZI®
(risankizumab-rzaa)?

SKYRIZI is a prescription medicine that may cause serious side effects, including: 

Serious allergic reactions:

  • Stop using SKYRIZI and get emergency medical help right away if you get any of the following symptoms of a serious allergic reaction:
    - fainting, dizziness, feeling lightheaded (low blood pressure)
    - swelling of your face, eyelids, lips, mouth, tongue, or throat
    - trouble breathing or throat tightness
    - chest tightness
    - skin rash, hives
    - itching

Infections:

SKYRIZI may lower the ability of your immune system to fight infections and may increase your risk of infections. Your healthcare provider should check you for infections and tuberculosis (TB) before starting treatment with SKYRIZI and may treat you for TB before you begin treatment with SKYRIZI if you have a history of TB or have active TB. Your healthcare provider should watch you closely for signs and symptoms of TB during and after treatment with SKYRIZI. 
  • Tell your healthcare provider right away if you have an infection or have symptoms of an infection, including:
    - fever, sweats, or chills
    - cough
    - shortness of breath
    - blood in your mucus (phlegm)
    - muscle aches
    - warm, red, or painful skin or sores on your body different from your psoriasis
    - weight loss
    - diarrhea or stomach pain
    - burning when you urinate or urinating more often than normal
Do not use SKYRIZI if you are allergic to risankizumab-rzaa or any of the ingredients in SKYRIZI. See the Medication Guide or Consumer Brief Summary for a complete list of ingredients.
 
Before using SKYRIZI, tell your healthcare provider about all of your medical conditions, including if you:
  • have any of the conditions or symptoms listed in the section “What is the most important information I should know about SKYRIZI?”
  • have an infection that does not go away or that keeps coming back.
  • have TB or have been in close contact with someone with TB.
  • have recently received or are scheduled to receive an immunization (vaccine). Medications that interact with the immune system may increase your risk of getting an infection after receiving live vaccines. You should avoid receiving live vaccines right before, during, or right after treatment with SKYRIZI. Tell your healthcare provider that you are taking SKYRIZI before receiving a vaccine.
  • are pregnant or plan to become pregnant. It is not known if SKYRIZI can harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if SKYRIZI passes into your breast milk.
  • become pregnant while taking SKYRIZI. You are encouraged to enroll in the Pregnancy Registry, which is used to collect information about the health of you and your baby. Talk to your healthcare provider or call 1-877-302-2161 to enroll in this registry.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of SKYRIZI?

SKYRIZI may cause serious side effects. See “What is the most important information I should know about SKYRIZI?”

The most common side effects of SKYRIZI in people treated for plaque psoriasis and psoriatic arthritis include: upper respiratory infections, headache, feeling tired, injection site reactions, and fungal skin infections.

These are not all the possible side effects of SKYRIZI. Call your doctor for medical advice about side effects.

Use SKYRIZI exactly as your healthcare provider tells you to use it.

SKYRIZI is available in a 150 mg/mL prefilled syringe and pen.

Please see the Full Prescribing Information, including the Medication Guide, for SKYRIZI.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

If you are having difficulty paying for your medicine, AbbVie may be able to help.
Visit AbbVie.com/myAbbVieAssist to learn more.

© 2023 AbbVie. All rights reserved. SKYRIZI® and its design are registered trademarks of AbbVie Biotechnology Ltd.

US-SKZD-230146

On-screen Text:
Skyrizi®
risankizumab-rzaa

abbvie